Research Context - Read Before Proceeding
All claims in this article reference preclinical (animal) or in vitro research unless explicitly stated otherwise. No compound discussed here is approved for human therapeutic use in South Africa unless specifically noted. Citations are provided for every material claim - see the References section below. This content is for scientific and educational purposes only. It does not constitute medical advice and must not be interpreted as a therapeutic recommendation. 18+ · Research use only.
The Research Variable Nobody Talks About
There is a category of research failure that generates no published data, produces no notable results, and teaches nothing - except that the researcher has wasted their time and money. It is the failure caused by using degraded compounds.
You can have the best research design in the world. You can source from a verified supplier with an impeccable manufacturer batch documentation. You can have high-purity research grade confirmed by an independent laboratory. And then you can leave your peptide on a warm counter for two hours, or receive it after a courier left it in a hot delivery vehicle for a day, and everything that came before is meaningless. You are no longer studying the compound. You are studying whatever the compound has degraded into. This applies whether you are working with BPC-157, TB-500, GHK-Cu, or any other lyophilised research compound.
This is not a minor risk. It is one of the most common sources of inconsistent results in peptide research. Understanding peptide chemistry explains why.
---
## What Happens to a Peptide at the Wrong Temperature
Peptides are short-chain amino acid polymers. Unlike small molecules - aspirin, caffeine, most pharmaceutical drugs - they are relatively fragile. Several degradation mechanisms operate at room temperature and accelerate significantly with heat:
Hydrolysis is the primary degradation pathway. Water molecules cleave the peptide bonds linking amino acids. In lyophilised (freeze-dried) form, this mechanism is largely arrested because water has been removed. Once in solution - after reconstitution - hydrolysis resumes and progresses continuously.
Oxidation is catalysed by light and heat. Specific amino acid side chains are vulnerable: methionine, tryptophan, cysteine, and tyrosine all have oxidation-susceptible groups. UV light in particular accelerates this process, which is why peptides should always be stored in opaque or amber vials.
Deamidation is a slower modification affecting asparagine and glutamine residues. It changes the charge state of the peptide and can alter receptor binding.
Temperature accelerates all of these mechanisms. A temperature excursion does not pause when you put the peptide back in the freezer. Whatever degradation occurred during that excursion is permanent.
---
## Two Completely Different Storage Regimes
The critical distinction in peptide storage is the difference between lyophilised and reconstituted states. These are not variations on the same storage problem - they have entirely different requirements.
Lyophilised (freeze-dried) peptides
This is the form research-grade research peptides are shipped in and should be received in. The peptide has been dissolved in water, then freeze-dried under vacuum. The resulting powder is stable because the primary degradation mechanism - hydrolysis - has been arrested by removing water.
Storage requirements: -20°C in a standard laboratory freezer. Stable for 24 months or longer at this temperature. Store in opaque vials protected from light. Keep a desiccant in the storage bag - lyophilised peptides are hygroscopic and will absorb ambient moisture if exposed to humid air.
Before opening a cold vial, allow it to equilibrate to room temperature - approximately 30-45 minutes. This is not optional. When you open a cold vial, warm moist air from the room enters and condenses on the cold surface. That condensed moisture introduces water directly to your lyophilised powder, initiating hydrolysis before you have even begun reconstitution. Equilibrate first. Always.
Reconstituted peptides
Once you add bacteriostatic water, the compound's stability properties change entirely. Hydrolysis resumes. You are now on a clock.
Storage requirements: 2-8°C (standard refrigerator, not freezer). Use within 28-30 days. Do not refreeze. Ice crystal formation during freeze-thaw cycles physically damages reconstituted peptides - the crystals disrupt molecular structure, and each freeze-thaw cycle progressively reduces potency. Protect from light.
Why 28-30 days specifically? The benzyl alcohol in bacteriostatic water inhibits microbial growth, but it does not stop chemical degradation. Hydrolysis continues at refrigerator temperature - just slowly enough that your compound retains meaningful activity for roughly a month. After that, what is in your vial is increasingly different from what your CoA documented.
---
## Cold-Chain Delivery: What It Means and How to Verify It
Cold-chain means the compound is maintained at the required temperature from the point of manufacture through to your door. A single temperature excursion anywhere in that chain can represent months of accelerated degradation.
A properly cold-chain dispatched order arrives in insulated packaging - styrofoam or polyurethane-lined boxes - with ice packs or dry ice appropriate to the transit duration and season. The packaging should still be cold on arrival. The ice packs should still be solid or cool. Your vials should arrive as lyophilised powder - if there is liquid in a vial that should be lyophilised, either the seal has failed or the product was never properly freeze-dried.
Check these four things when your order arrives: Is the outer packaging still cold? Are the cooling media still effective? Are the vials intact with lyophilised powder visible? Is manufacturer documentation included or accessible?
If any of these checks fail, contact your supplier before proceeding. Using a peptide with unknown cold-chain history is not valid research - you do not know what you are working with. For broader context on research validity, see our guide on manufacturer batch documentation verification.
---
## The Reconstitution Protocol
Do this correctly every time. There is no shortcut.
Allow the lyophilised vial to reach room temperature before opening - 30-45 minutes. Prepare your bacteriostatic water in a separate syringe. Inject the solvent slowly down the inner wall of the vial, not directly onto the powder. Swirl gently until the powder is fully dissolved. Do not shake or vortex - mechanical agitation applies stress to peptide bonds.
Inspect the resulting solution. It should be clear or very slightly off-white. Cloudiness, visible particulate matter, or unusual discolouration indicates a problem with either the compound or the reconstitution process.
Label the vial immediately: compound name, concentration, date reconstituted, lot number from the CoA. That lot number cross-reference is how you know your data corresponds to a verified compound.
Store at 2-8°C. Do not refreeze.
Calculating your working concentration:
If your vial contains 5mg of lyophilised BPC-157 and you add 2.5mL of bacteriostatic water, your working concentration is 5mg / 2.5mL = 2mg/mL = 2000mcg/mL. Adjust the volume of solvent you add to achieve the concentration appropriate for your research protocol.
---
## The Mistakes That Invalidate Research
| Mistake | What It Actually Does |
| Using reconstituted peptides past 30 days | Progressive potency loss - your dosing assumptions no longer correspond to actual compound concentration |
Each of these mistakes does the same thing: it means you are not studying the compound you think you are studying. That is the research validity problem. It is not just wasteful - it is the kind of variable that makes data uninterpretable.
---
## Frequently Asked Questions
Q: How should peptides be stored in South Africa? A: Lyophilised (freeze-dried) peptides should be stored at -20°C in a standard freezer in opaque vials. Once reconstituted with bacteriostatic water, store at 2–8°C (refrigerator) and use within 28–30 days. South Africa's warm climate makes temperature control especially important - do not leave peptides at room temperature or in vehicles.
Q: What is cold-chain for peptides? A: Cold-chain means the compound is kept at the required temperature continuously - from manufacture through storage, shipping, and delivery to you. A single temperature excursion accelerates peptide degradation permanently. A compliant supplier ships peptides in insulated packaging with ice packs or dry ice appropriate to SA transit times and climate.
Q: Can peptides be refrozen after reconstitution? A: No. Once reconstituted in bacteriostatic water, do not refreeze. Ice crystal formation during freeze-thaw cycles physically damages the peptide's molecular structure, reducing potency on every cycle. Reconstituted peptides should be refrigerated at 2–8°C and used within 30 days only.
Q: What happens if a peptide gets too warm? A: Heat accelerates hydrolysis (peptide bond cleavage), oxidation of vulnerable amino acid side chains, and deamidation. These are irreversible chemical changes. If your peptide was exposed to heat during shipping or storage, the actual purity and potency at your point of use may be substantially below what the CoA documents. This is not a recoverable situation - the degradation is permanent.
Q: How do I verify cold-chain integrity when my peptides arrive? A: Check four things: (1) Is the outer packaging still cold to the touch? (2) Are ice packs still solid or cool? (3) Are the vials intact with lyophilised powder visible (not liquid)? (4) Is manufacturer documentation included? If any check fails, contact your supplier before using the compounds.
Q: Why must I let peptide vials warm to room temperature before opening? A: When you open a cold vial, warm moist air from the room enters and condenses on the cold surface. That condensation introduces water directly into your lyophilised powder, initiating hydrolysis before you have even started reconstitution. Always allow 30–45 minutes for vials to equilibrate to room temperature before opening.
---
## References
1. Manning MC, et al. (2010). Stability of protein pharmaceuticals: an update. Pharm Res. 27(4):544–575. PMID: 20143256
18+ only. Research use only. Not for human consumption.